Dongwoon Anatech동운아나텍
094170 · KOSDAQ · ₩094170 · 동운아나텍
What brokers say about Dongwoon Anatech
Calculated by JONBUR from publicly available broker reports. Reports belong to their publishers. Not financial advice. Includes brokers that publish research publicly; some brokers' reports are client-only and not included.
AI summary of public information
An AI summary of the public information on this company: filed financial statements, filings, prices and news headlines. It doesn't use broker reports; their targets and estimates are shown above.
Dongwoon Anatech swung to a trailing operating loss in H1 2026 while its share price has fallen sharply over the past three months.
Dongwoon Anatech is a Korean fabless chip designer selling camera, automotive and lidar driver chips, with trailing twelve-month revenue of ₩124B and an operating loss of ₩6.9B. Its trailing net income of ₩20.3B is well above operating income, and the data does not explain the gap. The share price closed at ₩19,670 on 2026-10-27, down 28.1% over one month and 26.3% over three months, though still up 16.8% over one year.
What stands out
- Trailing operating margin is -5.6%, after a profitable 2023 and 2024 and a small profit of 1.9% in 2025.
- Annual revenue fell 7.7% in 2025 to ₩127.6B, and trailing revenue is about ₩124B.
- Trailing net income of ₩20.3B is far above the operating loss, so non-operating items or one-offs likely matter, but the data does not say what they are.
- Cash of ₩62.8B exceeds borrowings of ₩16B, and trailing free cash flow is about ₩2.9B.
- Recent filings and news cover a treasury share retirement worth about ₩13B, a shareholder meeting notice, and advisory contracts for licensing and a healthcare technology project.
What to watch
- The upcoming shareholder meeting and the share cancellation decision, both recorded in the filings list.
- Whether the company returns to an operating profit in its next reported period, since the trailing figure is negative.
- The reason for the gap between the operating loss and the net profit, and the outcome of the licensing and healthcare initiatives, which the data does not quantify.
Data as of Oct 27, 2026 · written yesterday
This is not financial advice.
Also known as: Dongwoon Anatech / 동운아나텍 / 094170 / KRX:094170
Source: KRX statistical information